The last announcement (In2pharma) was in my opinion positive but did little to the share price. what do we think investors are waiting for?
1. results of the trial
2. revenue/profit (finally becoming profitable)
3. release of our 2 new products
4. more deals/partnerships
I'm still bullish on the fundamentals and as Mackyinoz pointed out, which I agree, it feels very undervalued at this level.
The last announcement (In2pharma) was in my opinion positive but...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
